Are Oral Contraceptives Safe? Discover the Benefits and Risks!

Pallavi Madhiraju- July 20, 2024 0

Oral contraceptive pills, commonly known as birth control pills, rank second only to sterilization as a method of birth control. These pills are a popular ... Read More

Big pharma shakeup: Lupin sells women’s health arm for mega millions

Pallavi Madhiraju- July 15, 2024 0

Lupin Limited, a global pharmaceutical leader, has officially divested its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, Inc., a company specializing in women's ... Read More

Materna Medical launches POMPOM study to explore treatment for vaginismus with Milli Vaginal Dilator

Pallavi Madhiraju- June 6, 2024 0

Materna Medical, Inc., a leader in women's pelvic health solutions, has initiated the Prospective On Market Patient-reported Outcomes for Milli Vaginal Dilator (POMPOM) study. This ... Read More

Exploring Amenorrhea : Types, causes, and implications for women’s health

pharmanewsdaily- June 1, 2024 0

Amenorrhea is a medical term that signifies the absence of menstrual periods in women who are within their reproductive age. This condition is not a ... Read More

Dr. Reddy’s Laboratories expands wellness portfolio with MenoLabs acquisition

Pallavi Madhiraju- January 4, 2024 0

In a significant move within the healthcare industry, Dr. Reddy's Laboratories Ltd. has announced the acquisition of the MenoLabs business, a prominent player in women's ... Read More

Vaginal Yeast Infection – symptoms and home remedies

Pallavi Madhiraju- February 22, 2023 0

What is a Vaginal Yeast Infection? A vaginal yeast infection refers to the excessive growth of yeast cells within the vagina. The majority of yeast ... Read More

Mylan launches generic Estradiol Vaginal Cream after securing FDA approval

pharmanewsdaily- December 30, 2017 0

Mylan, a global pharmaceutical company, has recently announced the U.S. Food and Drug Administration (FDA) approval of its Estradiol Vaginal Cream USP, 0.01%, a generic ... Read More

Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

pallavi123- October 15, 2017 0

Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at ... Read More